^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CLM-103

    i
    Other names: CLM-103, YYB-103
    Associations
    News
    Trials
    Company:
    CellabMed, Yooyoung Pharma
    Drug class:
    IL-13Rα2-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials